Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Nutex Health (NUTX) over the last 15 years, with Q3 2025 value amounting to -$2.3 million.

  • Nutex Health's Other Working Capital Changes fell 58192.77% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.0 million, marking a year-over-year increase of 85524.85%. This contributed to the annual value of $7.0 million for FY2024, which is 75905.25% up from last year.
  • Latest data reveals that Nutex Health reported Other Working Capital Changes of -$2.3 million as of Q3 2025, which was down 58192.77% from $7.3 million recorded in Q2 2025.
  • In the past 5 years, Nutex Health's Other Working Capital Changes ranged from a high of $7.3 million in Q2 2025 and a low of -$4.2 million during Q4 2022
  • Its 5-year average for Other Working Capital Changes is $835082.1, with a median of -$70912.0 in 2021.
  • The largest annual percentage gain for Nutex Health's Other Working Capital Changes in the last 5 years was 27314350.0% (2021), contrasted with its biggest fall of 15186475.0% (2021).
  • Over the past 5 years, Nutex Health's Other Working Capital Changes (Quarter) stood at -$181889.0 in 2021, then plummeted by 2230.88% to -$4.2 million in 2022, then soared by 30.31% to -$3.0 million in 2023, then surged by 291.56% to $5.7 million in 2024, then tumbled by 140.0% to -$2.3 million in 2025.
  • Its Other Working Capital Changes was -$2.3 million in Q3 2025, compared to $7.3 million in Q2 2025 and $1.4 million in Q1 2025.